7 medtech stories we missed this week: Sept. 29, 2017

[Image from unsplash.com]From EOI getting FDA clearance to Sanuwave’s new joint venture agreement, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. EOI wins FDA nod for FLXfit15 expandable cage EOI announced in a Sept. 28 press release that it has received FDA 510(k) clearance for its FLXfit 15. The clearance will help enhance the company’s FLXfir 3D expandable cage system and help expand the surgeon’s flexibility and capability by offering different length options. 2. ivWatch inks distribution deal with Terumo ivWatch has recently signed a licensing and distribution agreement with Terumo to improve patient safety, according to a Sept. 21 press release. Terumo will become the exclusive distributor of the ivWatch Model 400 and ivWatch OEM board in Japan. ivWatch technology can be integrated with other patient monitoring systems, infusion pumps and other devices easily with the ivWatch OEM board. The agreement also allows Terumo to exclusively integrate ivWatch into existing and future Terumo products in Japan. 3. FDA clears Mortise Medical’s LigaMetrics suture anchor system Mortise Medical announced in a Sept. 26 press release that it has received FDA 510(k) clearance for its LigaMetrics Suture Anchor System. The LigaMetrics Suture Anchor System is the first and only knotless suture anchor that allows for precise, measured tension control of the suture repair construct. The system is designed to connect to and lo...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Clinical Trials Diagnostics Food & Drug Administration (FDA) Cefaly EOI ivwatch Lombard Medical MedTech Mortise Medical Mundimed Sanuwave Terumo Varian Medical Systems Source Type: news